P
PODD icon

&Partners’s Insulet PODD Stock Holding History

&Partners’s Portfolio PODD Stock Details PODD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$482K Sell
2,295
-1,021
-31% -$257K ﹤0.01% 1716
2025
Q4 		$941K Sell
3,316
-1,162
-26% -$363K ﹤0.01% 1252
2025
Q3 		$1.38M Buy
4,478
+440
+11% +$138K 0.01% 936
2025
Q2 		$1.27M Buy
4,038
+2,138
+113% +$617K 0.01% 867
2025
Q1 		$492K Buy
1,900
+656
+53% +$178K 0.01% 1142
2024
Q4 		$331K Buy
1,244
+342
+38% +$86.1K ﹤0.01% 1282
2024
Q3 		$217K Buy
+902
New +$185K ﹤0.01% 1269

Other funds holding PODD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

&Partners's PODD Position: Q1 2026 in Review

&Partners reduced its Insulet (PODD) stake by 31% in Q1 2026, selling an estimated $257K and leaving 2,295 shares worth $482K. The position accounts for ﹤0.01% of the portfolio, ranked #1716.

&Partners first reported a position in PODD in Q3 2024 and has held it in 7 quarters since. The position peaked at $1.38M in Q3 2025. 784 funds tracked by Wall St. Rank hold PODD as of Q1 2026.

  • &Partners held 2,295 shares of Insulet worth $482K as of Q1 2026.
  • &Partners sold 1,021 Insulet shares in Q1 2026, an estimated $257K.
  • Insulet made up ﹤0.01% of &Partners's portfolio in Q1 2026, its #1716 holding.
  • &Partners first reported a position in Insulet in Q3 2024 and has held it in 7 quarters since.
  • &Partners's Insulet position peaked at $1.38M in Q3 2025.
  • 784 funds tracked by Wall St. Rank held Insulet as of Q1 2026.

Based on &Partners's 13F filing for Q1 2026, filed 15 May 2026.